A digital health company offering an AI-based treatment programme for people with mild cognitive impairment, dementia, or subjective cognitive decline. It combines an AI companion, Sunny, with regular telehealth sessions with clinicians to deliver interventions shown in over 300 clinical trials and 50+ meta-analyses. The approach rests on structured conversations, cognitive stimulation, training, and rehabilitation.

Sector: Health, Native AI
Role: Advisor, Investor
Status: Current
Investment date: 2025
Location: United States
Website: newdays.ai